Programmable biology is being explored as a means to advance biologic drug development. Research in this area involves various approaches, including the use of silicon chips and mitochondrial engineering, and may be aided by technologies such as artificial intelligence. The potential applications and implications of programmable biology are still emerging and may involve new risks and opportunities in fields such as biotech and biology.